Moxaverine hydrochloride
Moxaverine hydrochloride is a phosphodiesterase (PDE) inhibitor. Moxaverine hydrochloride also interacts with calmodulin (calmodulin), thereby enhancing the inhibition of calmodulin-dependent PDE. Moxaverine hydrochloride can be used in studies related to microcirculation regulation and ocular tissue distribution.
For research use only. We do not sell to patients.
- CAS No.: 1163-37-7
- Formula: C20H22ClNO2
- Molecular Weight:343.85
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Moxaverine hydrochloride (10−5-10−2 M; in hypertonic conditions of 400 mosmol/L and lactic acidosis at pH 6.8) restores the normal discoid morphology of stressed red blood cells and improves their microrheological filtration performance under low shear stress conditions[1].
14C-labeled moxaverine hydrochloride (33 μM; up to 4 h) exhibits high bidirectional permeability in HCE-T, C-HCE, ex vivo human cornea and ex vivo rabbit cornea models, with Papp values of 13.42/17.49, 5.84/6.82, 5.42/3.76 and 5.16/2.39 × 10−6 cm/s for the apical-to-basolateral/basolateral-to-apical directions, respectively[3].
14C-labeled moxaverine hydrochloride efficiently permeates through primary rabbit corneal epithelial cell layers. It shows no significant transport directionality in the presence or absence of benzalkonium chloride and EDTA, indicating that its corneal absorption mainly occurs via transcellular passive diffusion[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
After intravenous administration to male Dutch-belted pigmented rabbits, moxaverine hydrochloride (1.28 × 10−3 M; i.v.; 14C tracing; 30 and 120 min) can penetrate into the retina, but its retinal content decreases at 120 min compared with that at 30 min; its scleral contents at both 30 and 120 min are lower than those after topical ocular administration[5].
Moxaverine hydrochloride (50 μL/eye; topical ocular administration; 14C-moxaverine-HCl tracing; 30 and 120 min) distributes mainly in the conjunctiva, cornea and iris/ciliary body in male Dutch-belted pigmented rabbits, with no measurable levels detected in the lens; the concentration in the retina is comparable to that after intravenous administration at 30 min, and higher than that after intravenous administration at 120 min, while the plasma level after topical ocular administration is lower than that after intravenous administration[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Dutch-belted (male, pigmented)[2]
-
Dosage:50 μL (topical ocular)
-
Administration:topical ocular (each eye)
-
Result:Detected the highest levels in the conjunctiva, cornea, and iris/ciliary body, with no measurable level in the lens.
Achieved retinal concentrations comparable to i.v. administration at 30 min and higher than i.v. administration at 120 min, while producing lower plasma levels than systemic administration.
Chemical Information
-
CAS No. 1163-37-7
-
Molecular Weight 343.85
-
Formula C20H22ClNO2
-
SMILES
COC1=CC(C=C(CC)N=C2CC3=CC=CC=C3)=C2C=C1OC.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)